Relative biological effectiveness of photon energies used in brachytherapy and intraoperative radiotherapy techniques for two breast cancer cell lines

Acta Oncologica

Volumn 49, Issue 8, 2010, Pages 1261-1268

  Marthinsen, Anne B L ^a   Gisetstad, Ragnhild ^a   Danielsen, Signe ^a   Frengen, Jomar ^a   Strickert, Trond ^a   Lundgren, Steinar ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IRIDIUM 192;

ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL SURVIVAL; CLINICAL EVALUATION; CLONOGENIC ASSAY; COLONY FORMATION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HUMAN CELL; INTRAOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RELATIVE BIOLOGIC EFFECTIVENESS;

BRACHYTHERAPY; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; NEOPLASM STAGING; PHOTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 77958197938     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.504226     Document Type: Article

References (25)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995;333:1444-55.
2. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-year results after sector resection with or without postpoperative radiotherapy for stage I breast cancer. J Clin Oncol 1999;17:2326-33.
3. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001;12:997-1003.
4. Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: New primary tumours have more favourable outcomes than true local disease recurrences. Cancer 2002;95:2059-67.
5. Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007:194:456-62.
6. Kraus-Tiefenbacher U, Bauer L, Scheda A, Fleckenstein K, Keller A, Herskind C, et al. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. Int J Radiat Oncol Biol Phys 2006;66:377-81.
7. Polgar C, Strnad V, Major T. Brachytherapy for partial breast irradiation: The European experience. Semin Radiat Oncol 2005;15:116-22. (Pubitemid 40432416)
8. Reitsamer R, Peintinger F, Sedlmayer F, Kopp M, Menzel C, Cimpoca W, et al. Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients. Eur J Cancer 2002;38:1607-10.
9. Tobias JS, Vaidya JS, Keshtgar M, Douek M, Metaxas M, Stacey C et al. Breast-conserving surgery with intra-operative radiotherapy: The right approach for the 21st century? Clin Oncol 2006;18:220-8.
10. Vaidya JS, Tobias JS, Baum M, Wenz F, Kraus-Tiefenbacher U, D'Souza D, et al. TARGeted Intraoperative radiotherapy (TARGIT): An innovative approach to partial-breast irradiation. Semin Radiat Oncol 2005;15:84-91.
11. Vicini FA, Arthur DW. Breast brachytherapy: North American experience. Semin Radiat Oncol 2005;15:108-15.
12. Buchholz T, Kuerer HM, Strom EA. Is partial breast irradiation a step forward or backward? Semin Radiat Oncol 2005;15:69-75.
13. MacDonald SM, Taghian AG. Partial-breast irradiation: Towards a replacement for whole-breast irradiation? Expert Rev Anticancer Ther 2007;7:123-34.
14. Offersen BV, Overgaard M, Kroman N, Overgaard J. Accelerated partial breast irradiation as a part of breast conserving therapy of early breast carcinoma: A systematic review. Radiother Oncol 2009;90:1-13.
15. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009;74:987-1001.
16. Cuncins-Hearn A, Saunders C, Walsh D, Borg M, Buckingham J, Frizelle F, et al. A systematic review of intraoperative radiotherapy in early breast cancer. Breast Cancer Res Treat 2004;85:271-80.
17. Hunter N, Muirhead CR. Review of relative biological effectiveness dependence on linear energy transfer for low LET radiation. J Radiol Prot 2009;29:5-21.
18. Brenner DJ, Leu C-S, Beatty JF, Shefer RE. Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices. Phys Med Biol 1999;44:323-33.
19. Herskind C, Steil V, Kraus-Tiefenbacher U, Wenz F. Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer. Radiat Res 2005;163:208-15.
20. Astor MB, Hilaris BS, Gruerio A, Varricchione T, Smith D. Preclinical studies with the photon radiosurgery system (PRS). Int J Radiat Oncol Biol Phys 2000;47:809-13.
21. Lehnert A, Lessmann E, Pawelke J, Dörr W. RBE of 25kV X-rays for the survival and induction of micronuclei in the human mammary epithelial cell line MCF-12A. Radiat Environ Biophys 2006;45:253-60.
22. Steel GG. The dose rate effect: Brachytherapy and targeted radiotherapy. In: Basic clinical radiobiology. Steel GG. London: Arnold; 2002. pp. 192-204.
23. Trabalka JR, Kocher DC. Energy dependence of dose and dose-rate effectiveness factor for low-let radiations: Potential importance to estimation of cancer risks and relationship to biological effectiveness. Health Phys 2007;93:17-27.
24. Butson MJ, Cheung T, Yu P K N. Weak energy dependence of EBT gafcromic film dose response in the 50 kVp-10 MVp X-ray range. Appl Radiat Isot 2005;64:60-2.
25. Saur S, Frengen J. GafCromic EBT film dosimetry with flatbed CCD scanner: A novel background correction method and full dose uncertainty analysis. Med Phys 2008;35:3094-101.